18プログラム
2日目

第6会場 南館 4F「錦」

The 15th International Gastrointestinal Consensus Symposium（IGICS）
9：00〜9：02

Opening Remarks

Topic：Progress and current status of IBD（inflammatory bowel disease）treatment

Chairperson： Satoshi Motoya（IBD center, Sapporo Kosei general hospital. Sapporo.
JAPAN）

9：02〜10：06

Oral Session 1
Chairs： Satoru Yamaguchi（Department of Surgery, Dokkyo Medical University
Nikko Medical Center）
Tiing Leong Ang（Department of Gastroenterology and Hepatology,
Changi General Hospital, Singapore；Duke-NUS MedicalSchool；Yong Loo Lin School of Medicine, National University of Singapore）
Varayu Prachayakul（Division of Gastroenterology ＆ Hepatology, Department of Internal Medicine, Siriraj Hospital MahidolUniversity）
Commentator： Hidekazu Suzuki（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University
School of Medicine）

第6会
場

IO1-1

Impact of alcohol on viral hepatitis infection in hepatocellular carcinoma patients who underwent transarterial
chemoembolization

Attapon Rattanasupa（Division of Gastroenterology, Department of Internal Medicine, Hatyai
Hospital, Songkhla, Thailand）
IO1-2

Prevalence of Papilla Subtypes and Impact on Successful Biliary Cannulation and Duration of ERCP：ASingle-Center Experience

LIEW Sherilyn Zi Hui（Department of Gastroenterology ＆ Hepatology, Changi General Hospital, Singapore）
IO1-3

A case of mid ileum endometriosis presenting as small bowel intussusception treated by single balloon enteroscopy with endoscopic full thickness resection

Jiang Bochao（Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore）
IO1-4

What should we do about dietary intake after esophageal cancer surgery?

Yoshihiro Tanaka（Gifu University, school of medcine, Gastroenterological surgery）
IO1-5

Seven-day vonoprazan vs 14-day proton pump inhibitor based triple therapy for first-line Helicobacter pylori
eradication：A prospective randomized study in a multiracial Asian population

Daphne Ang（Department of Gastroenterology, Changi General Hospital, Singapore）― 62 ―

18

第6会場 南館 4F「錦」
IO1-6

External validation and comparison of the Oakland score and other scoring systems in predicting clinical outcomes of acute lower gastrointestinal bleeding

プロ
グラム
2
日目

Kamales Prasitvarakul（Division of Minimally Invasive Surgery, Department of Surgery, Hatyai
Hospital, Songkhla, Thailand）
IO1-7E3 ligase IRF2BPL inhibits M2 macrophage polarization through suppressing tumour extrinsic β-catenin pathway

Yujuan Celia DONG（Department of Surgery, The Chinese University of Hong Kong）
IO1-8

LONGITUDINAL MULTI-OMICS REVEALS SUBSET-SPECIFIC MECHANISMS UNDERLYING BENEFICIALEFFECTS OF SIM01 ON COVID-19

Lin ZHANG（Department of Medicine ＆ Therapeutics, Center for Gut Microbiota Research,
The Chinese University of Hong Kong）

10：06〜10：09

Greetings from chairperson of international exchange committee
Presenter： Akiko Shiotani（Kawasaki Medical School）

10：09〜10：23

Report on Questionnaire
Presenter： Satoshi Motoya（IBD center, Sapporo Kosei general hospital. Sapporo.
JAPAN）

10：23〜11：03

第6会場

Oral Session 2Chairs： Akiko Shiotani（Kawasaki Medical School）
Francis K.L. Chan（Dean, Faculty of Medicine, The Chinese University ofHong Kong）
Commentator： Toshio Watanabe（Department of Premier Preventive Medicine,
Osaka City University Graduate School of Medicine）

IO2-1

Educational and Employment Profile of Inflammatory Bowel Disease Patients in Cipto Mangunkusumo Hospital：A Descriptive Study

Muhammad Firhat Idrus（Division of Gastroenterology, Pancreatobiliary, and Digestive Endoscopy, Department of Internal Medicine, Dr Cipto Mangunkusumo
Hospital, Jakarta, Indonesia）
IO2-2

Accuracy of thigh circumference and calf circumference as screening modalities of sarcopenia in inflammatory
bowel disease（IBD）patient

Rabbinu Rangga Pribadi（Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia）― 63 ―

18

プロ
グラム
2日目

第6会場 南館 4F「錦」
IO2-3

Vitamin D status and disease activity in inflammatory bowel disease：Indonesia experience

Oryza Gryagus Prabu（Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Jakarta,Indonesia）
IO2-4

The comparison of the serum trough concentration of Infliximab with leucine rich alpha2 glycoprotein in the patients with inflammatory bowel disease

Osamu Handa（Dept of Internal Medicine, Division of Gastroenterology, Kawasaki MedicalSchool）
IO2-5

MRI-based radiomic signature identifying secondary loss of response to Infliximab for Crohnʼs disease

Shen Jun（Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology
and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center；
Renji Hospital, School of Medicine, Shanghai Jiao Tong University；Shanghai Institute of Digestive Disease；160# Pu Jian Ave, Shanghai 200127）

11：03〜11：51

Oral Session 3
Chairs： Tadakazu Hisamatsu（Kyorin University School of Medicine）
Murdani Abdullah（Division of Gastroenterology, Faculty of Medicine, Universitas Indonesia）
Commentator： Yuji Naito（Kyoto Prefectural University of Medicine）

IO3-1

Inflammatory Bowel Disease Therapy in National Referral Hospital in Indonesia

Virly Nanda Muzellina（Division of Gastroenterology, Department of Internal Medicine, Medical
Faculty University of Indonesia/Cipto Mangunkusumo National General Hospital）

第6会場

IO3-2

Recurrent Perianal Fistula in a Patient with Crohnʼs Disease：A Case Report

Saskia Aziza Nursyirwan（Division of Gastroenterology, Pancreatobiliary, and Digestive Endoscopy, Department of Internal Medicine, Dr Cipto Mangunkusumo
Hospital, Jakarta, Indonesia）
IO3-3

Cancelled

IO3-4

Clinical effects of Ustekinumab and mucosal treatment in ulcerative colitis

Yuka Fukuo（Department of Gastroenterology, Juntendo University）
IO3-5

Efficacy of Ustekinumab with moderately to severely active ulcerative colitis：Two-centre cohort study in JapanMasaki Kato（Division of Gastroenterology and Hepatology, Department of Internal Medicine,St. Marianna University School of Medicine）
IO3-6

Corticosteroid-free remission of Ulcerative Colitis with filgotinib maintenance therapy：Post hoc analysis of thephase 2b/3 SELECTION study

Toshifumi Hibi（Kitasato Institute Hospital- Kitasato University, Center for Advanced IBD Research and Treatment, Tokyo, Japan）― 64 ―

18

第6会場 南館 4F「錦」
11：51〜11：55

プログラム
2日目

Closing Remarks
Chairperson： Satoshi Motoya（IBD center, Sapporo Kosei general hospital. Sapporo.
JAPAN）

第6会場― 65 ―